The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara and Novo Nordisk’s Novolog. The Trump administration announced in August ...

Most forms of income count as taxable — but not all. Here’s how to calculate yours and some ways to reduce your liability. Many, or all, of the products featured on this page are from our advertising ...

While speaking to press about fertility treatments, Donald Trump struggled to pronounce the fertility medicine Pergoveris, then jokingly asked why it couldn't have a 'nice, simple name.' ‘Adult female ...

COULD ACTUALLY BE MUCH MORE ACCURATE. A MARY SALADNA IS IN THE NEWSROOM AND MARY THE RESULTS AREN’T GOOD. NO, THEY’RE NOT, BUT THE RESULTS ARE MORE REALISTIC AND MORE PROOF THAT BODY COMPOSITION ...

The prevalence of obesity in the United States could rise sharply under a definition of obesity released earlier this year by the Lancet Diabetes and Endocrinology Commission. Additionally, the ...

Johnson & Johnson (NYSE:JNJ) on Tuesday reported a third-quarter 2025 adjusted earnings of $2.80 per share, up 15.7% year over year, beating the consensus of $2.75. The pharmaceutical and medtech ...

YONGIN, South Korea, Oct. 13, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed an agreement with Curevo Vaccine to secure ...

Her legacy will include the ways she shaped fashion, rather than allowing fashion to shape her. By Vanessa Friedman Diane Keaton, the Oscar-winning actress whose death at 79 was revealed this weekend, ...

Ustekinumab concentrations at week 8 of treatment were associated with better endoscopic outcomes in patients with inflammatory bowel disease (IBD) at week 24, with concentrations above 4.5 μg/mL ...

PALM BEACH GARDENS, FLORIDA / ACCESS Newswire / October 8, 2025 / Peek, a leading healthcare technology company, today announced the launch of PeekDirect™ pricing for IMULDOSA® (ustekinumab-srlf), a ...